104 related articles for article (PubMed ID: 19904744)
1. N-glycan based models improve diagnostic efficacies in hepatitis B virus-related hepatocellular carcinoma.
Fang M; Zhao YP; Zhou FG; Lu LG; Qi P; Wang H; Zhou K; Sun SH; Chen CY; Gao CF
Int J Cancer; 2010 Jul; 127(1):148-59. PubMed ID: 19904744
[TBL] [Abstract][Full Text] [Related]
2. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus.
Liu XE; Desmyter L; Gao CF; Laroy W; Dewaele S; Vanhooren V; Wang L; Zhuang H; Callewaert N; Libert C; Contreras R; Chen C
Hepatology; 2007 Nov; 46(5):1426-35. PubMed ID: 17683101
[TBL] [Abstract][Full Text] [Related]
3. Development of a highly sensitive glycan microarray for quantifying AFP-L3 for early prediction of hepatitis B virus-related hepatocellular carcinoma.
Wu CS; Lee TY; Chou RH; Yen CJ; Huang WC; Wu CY; Yu YL
PLoS One; 2014; 9(6):e99959. PubMed ID: 24927126
[TBL] [Abstract][Full Text] [Related]
4. Serum N-glycan profiling as a diagnostic biomarker for the identification of hepatitis B virus-associated hepatocellular carcinoma.
Guo L; Wan L; Hu Y; Huang H; He B; Wen Z
J Gastrointest Oncol; 2022 Feb; 13(1):344-354. PubMed ID: 35284106
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of the hemopexin N-glycan profile in hepatocellular carcinoma patients.
Debruyne EN; Vanderschaeghe D; Van Vlierberghe H; Vanhecke A; Callewaert N; Delanghe JR
Clin Chem; 2010 May; 56(5):823-31. PubMed ID: 20348404
[TBL] [Abstract][Full Text] [Related]
6. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
7. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma.
Guan W; Gao Z; Huang C; Fang M; Feng H; Chen S; Wang M; Zhou J; Hong S; Gao C
Glycoconj J; 2020 Apr; 37(2):231-240. PubMed ID: 31933068
[TBL] [Abstract][Full Text] [Related]
9. Specific N-glycans of Hepatocellular Carcinoma Cell Surface and the Abnormal Increase of Core-α-1, 6-fucosylated Triantennary Glycan via N-acetylglucosaminyltransferases-IVa Regulation.
Nie H; Liu X; Zhang Y; Li T; Zhan C; Huo W; He A; Yao Y; Jin Y; Qu Y; Sun XL; Li Y
Sci Rep; 2015 Nov; 5():16007. PubMed ID: 26537865
[TBL] [Abstract][Full Text] [Related]
10. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
[TBL] [Abstract][Full Text] [Related]
11. Soluble human leukocyte antigen-G expression in hepatitis B virus infection and hepatocellular carcinoma.
Park Y; Park Y; Lim HS; Kim YS; Hong DJ; Kim HS
Tissue Antigens; 2012 Feb; 79(2):97-103. PubMed ID: 22136460
[TBL] [Abstract][Full Text] [Related]
12. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
13. Identification of abnormal fucosylated-glycans recognized by LTL in saliva of HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Zhang J; Zhong Y; Zhang P; Du H; Shu J; Liu X; Zhang H; Guo Y; Jia Z; Niu L; Yang F; Li Z
Glycobiology; 2019 Mar; 29(3):242-259. PubMed ID: 30535277
[TBL] [Abstract][Full Text] [Related]
14. Rapid determination of serological cytokine biomarkers for hepatitis B virus-related hepatocellular carcinoma using antibody microarrays.
Liu T; Xue R; Dong L; Wu H; Zhang D; Shen X
Acta Biochim Biophys Sin (Shanghai); 2011 Jan; 43(1):45-51. PubMed ID: 21138899
[TBL] [Abstract][Full Text] [Related]
15. Serum peptide pattern that differentially diagnoses hepatitis B virus-related hepatocellular carcinoma from liver cirrhosis.
Wang N; Cao Y; Song W; He K; Li T; Wang J; Xu B; Si HY; Hu CJ; Li AL
J Gastroenterol Hepatol; 2014; 29(7):1544-50. PubMed ID: 24612022
[TBL] [Abstract][Full Text] [Related]
16. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
[TBL] [Abstract][Full Text] [Related]
17. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Wong GL; Chan HL; Tse YK; Chan HY; Tse CH; Lo AO; Wong VW
Hepatology; 2014 Mar; 59(3):986-95. PubMed ID: 24123097
[TBL] [Abstract][Full Text] [Related]
18. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
19. Assessing prognostic significance of preoperative alpha-fetoprotein in hepatitis B-associated hepatocellular carcinoma: normal is not the new normal.
Blank S; Wang Q; Fiel MI; Luan W; Kim KW; Kadri H; Mandeli J; Hiotis SP
Ann Surg Oncol; 2014 Mar; 21(3):986-94. PubMed ID: 24232510
[TBL] [Abstract][Full Text] [Related]
20. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing.
Vanhooren V; Liu XE; Franceschi C; Gao CF; Libert C; Contreras R; Chen C
Mech Ageing Dev; 2009; 130(1-2):92-7. PubMed ID: 19070631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]